Financhill
Buy
57

DSGN Quote, Financials, Valuation and Earnings

Last price:
$9.60
Seasonality move :
-15.75%
Day range:
$9.65 - $10.11
52-week range:
$2.60 - $10.31
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.74x
Volume:
939.8K
Avg. volume:
522K
1-year change:
59.36%
Market cap:
$546.9M
Revenue:
--
EPS (TTM):
-$1.19

Earnings Data

Next earnings date for DSGN
Mar 10
2026
Most recent earnings per share
-$0.30
Beat by $0.04
(Nov 5/2025)
Consensus Estimate
-$0.34
(Nov 5/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

DSGN Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/10/2026 Q4 -- -- -- -$0.33 --
11/05/2025 Q3 -- -- -$0.30 -$0.34 $0.04
08/06/2025 Q2 -- -- -$0.34 -$0.33 -$0.01
05/07/2025 Q1 -- -- -$0.31 -$0.28 -$0.03
03/10/2025 Q4 -- -- -$0.24 -$0.27 $0.03
11/07/2024 Q3 -- -- -$0.23 -$0.24 $0.01
08/05/2024 Q2 -- -- -$0.21 -$0.23 $0.02
05/08/2024 Q1 -- -- -$0.20 -$0.26 $0.07
03/19/2024 Q4 -- -- -$0.21 -$0.32 $0.11
11/13/2023 Q3 -- -- -$0.28 -- --
08/14/2023 Q2 -- -- -$0.36 -- --
05/09/2023 Q1 -- -- -$0.35 -- --
03/14/2023 Q4 -- -- -$0.31 -- --
11/03/2022 Q3 -- -- -$0.32 -- --
08/08/2022 Q2 -- -- -$0.27 -- --
05/09/2022 Q1 -- -- -$0.24 -- --
03/10/2022 Q4 -- -- -$0.20 -- --
11/09/2021 Q3 -- -- -$0.21 -- --
08/09/2021 Q2 -- -- -$0.14 -- --
05/10/2021 Q1 -- -- -$0.10 -- --
12/31/2020 Q4 -- -- -$0.07 -- --
09/30/2020 Q3 -- -- -$0.04 -- --
06/30/2020 Q2 -- -- -$0.03 -- --
03/31/2020 Q1 -- -- -$0.01 -- --

Design Therapeutics, Inc. Earnings Questions

  • How Much did Design Therapeutics, Inc. Generate in Revenue Last Quarter?

    Design Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Design Therapeutics, Inc. Beat Earnings Last Quarter?

    Design Therapeutics, Inc. announced earnings per share of -$0.30 which represents a beat of analyst forecast a -$0.34 per share.

  • Is Design Therapeutics, Inc. Profitable?

    Design Therapeutics, Inc. reported -$155K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Design Therapeutics, Inc. EPS Next Year?

    Design Therapeutics, Inc.'s earnings are forecast to decrease from -$0.88 per share to -$0.90 per share next year representing a decrease of -45.78%.

  • When is Design Therapeutics, Inc.'s Earnings Date?

    Design Therapeutics, Inc.'s next earnings date is March 10, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Is Bloom Energy The Best Stock to Buy Now?
Is Bloom Energy The Best Stock to Buy Now?

Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 24

Applied Optoelectronics, Inc. [AAOI] is up 2.7% over the past day.

Buy
85
HUT alert for Dec 24

Hut 8 Corp. [HUT] is up 0.32% over the past day.

Buy
63
GPCR alert for Dec 24

Structure Therapeutics, Inc. [GPCR] is down 2.75% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock